Current:Home > ContactCDC advisers back broad rollout out of new COVID boosters -PureWealth Academy
CDC advisers back broad rollout out of new COVID boosters
View
Date:2025-04-19 21:25:18
A panel of advisers to the Centers for Disease Control and Prevention backed the broad use of new COVID-19 vaccines, as cases of the respiratory illness rise.
The advisers voted 13-1 to recommend the vaccines for people ages 6 months and older. While the benefits appear to be greatest for the oldest and youngest people, the benefits of vaccination exceed the risks for everyone, according to a CDC analysis.
The universal recommendation, as opposed to one that applies to selected groups, could ease the rollout of the vaccine and improve access and equity.
"Let's keep America strong, healthy," said Dr. Camille Kotton, a panel member who voted in favor of the recommendation and who is an infectious disease specialist at Harvard Medical School. "Let's do away with COVID-19 as best we can by prevention of disease through vaccines. Let's make things clear."
The Food and Drug Administration gave the go-ahead to vaccines from Moderna and Pfizer-BioNTech Monday. A new vaccine from Novavax is under FDA review and may be approved soon.
The new vaccines target a much more recent variant of the omicron strain called XBB.1.5 that was selected by the FDA in June for use in formulating new vaccines. The idea, akin to how flu vaccines are made, is to match a seasonal vaccine to the virus that is infecting people.
Since the FDA's decision, other variants have overtaken XBB.1.5, but laboratory data suggest the new vaccines should provide good protection against COVID-19, including serious illness, hospitalization and death. The new shots can bolster immunity from previous vaccinations and COVID illness.
The last step before vaccination with the new shots can start is a formal decision by the CDC director. The decision is expected to quickly follow the panel's vote.
The new shots could become available as soon as Wednesday in some parts of the country. They're not technically free anymore, but for most people insurance will pay for them. The federal government will make the shots available for the uninsured at no cost.
veryGood! (2619)
Related
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Triathlon
- Logan Paul and Nina Agdal Are Engaged: Inside Their Road to Romance
- Kylie Jenner’s Recent Photos of Son Aire Are So Adorable They’ll Blow You Away
- In California, a Race to Save the World’s Largest Trees From Megafires
- Realtor group picks top 10 housing hot spots for 2025: Did your city make the list?
- Warming Trends: Climate Insomnia, the Decline of Alpine Bumblebees and Cycling like the Dutch and the Danes
- Freight drivers feel the flip-flop
- Texas Study Finds ‘Massive Amount’ of Toxic Wastewater With Few Options for Reuse
- Paris Hilton, Nicole Richie return for an 'Encore,' reminisce about 'The Simple Life'
- A troubling cold spot in the hot jobs report
Ranking
- What do we know about the mysterious drones reported flying over New Jersey?
- A 3-hour phone call that brought her to tears: Imposter scams cost Americans billions
- Why Danielle Jonas Sometimes Feels Less Than Around Sisters-in-Law Priyanka Chopra and Sophie Turner
- The OG of ESGs
- Don't let hackers fool you with a 'scam
- These Secrets About Grease Are the Ones That You Want
- Nueva página web muestra donde se propone contaminar en Houston
- Inside Clean Energy: Solid-State Batteries for EVs Make a Leap Toward Mass Production
Recommendation
Rylee Arnold Shares a Long
NPR's Terence Samuel to lead USA Today
Jonah Hill's Ex Sarah Brady Accuses Actor of Emotional Abuse
Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement
Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
Grimes used AI to clone her own voice. We cloned the voice of a host of Planet Money.
Q&A: How White Flight and Environmental Injustice Led to the Jackson, Mississippi Water Crisis
And the award goes to AI ft. humans: the Grammys outline new rules for AI use